Know Cancer

forgot password

Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium

21 Years
Not Enrolling
End Stage Renal Disease (ESRD)

Thank you

Trial Information

Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium


- End stage renal disease (ESRD) is the near-total loss of kidney function which can
result from a variety of diseases. ESRD disproportionately affects African Americans;
this group comprises 29% of all ESRD patients treated in the Medicare ESRD program, a
proportion that markedly exceeds their representation in the general population.

- The Family Investigation of Diabetes and Nephropathy (FIND) study is an ongoing study
to identify susceptibility genes for diabetic and other forms of nephropathy, and the
Choices for Healthy Outcomes in Caring for ESRD patients (CHOICE) study is an ongoing
prospective study to identify risk factors for cardiovascular outcomes in ESRD
patients. Participants of these studies have already been recruited and characterized
with respect to renal phenotypes; furthermore, DNAs from these individuals have already
been collected and isolated. In this study, we intend to genotype markers suitable for
MALD analysis in African Americans. The central hypothesis of the present study is
that some renal disease susceptibility alleles are present at higher frequency in
African Americans than in whites and that specific regions of the genome in African
Americans contain marker alleles that are in admixture linkage disequilibrium with ESRD
susceptibility alleles.


- The overall objective of this study is to identify novel loci, genes, and gene
products, that may partially account for excess risk of end stage renal disease (ESRD)
in African Americans compared to whites.

- To achieve this goal, we will employ Mapping by Admixture Linkage Disequilibrium (MALD)
analysis, a specialized form of linkage disequilibrium mapping, to perform a
genome-wide association study in approximately 2,500 African-American participants from
the FIND and CHOICE studies.


- Specific Inclusion/Exclusion criteria: African American

- Gender and minority inclusion. The FIND and CHOICE studies are open to both men and
women of any ethnicity; however, due to the underlying principle of MALD analysis, this
study will only include African-American participants of these cohorts.


- Genotype 1536 African-American MALD markers (2 cM average spacing) utilizing DNA from
approximately 2,500 African-American participants in FIND and CHOICE.

- Perform a genome-wide association analysis utilizing a 2 cM dense genetic map and
identify chromosomal loci that are in admixture linkage disequilibrium with:

- ESRD in a case-control design

- ESRD attributable to diabetes in a case-control design

- Quantitative renal phenotypes

- Fine map putative chromosomal region in admixture linkage disequilibrium with ESRD with
densely-spaced single nucleotide polymorphisms.

- A characterization of the MYH9 gene, its mRNA and the proteins encoded is planned for
cases and controls. Gene sequencing of the region implicated will be undertaken.
Characterization of mRNA products for quantities and alternative splicing will be
evaluated. Experimental characterization of the MYH9 proteins for isoforms,
post-translational modifications, interactions, and immunohistochemical staining will
be performed.

Inclusion Criteria


The cohorts utilized in this study, FIND and CHOICE, are open to adults of both genders
and any ethnicity. However, we will select and utilize only those samples from African -
American participants. We will also utilize African (Yorban) and European controls for
genotyping from the NIGMS HGCR.


Children and all ethnicities other than African - American, African, and European will be
excluded from this study.

Type of Study:


Study Design:


Principal Investigator

Martha Linet, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)


United States: Federal Government

Study ID:




Start Date:

June 2006

Completion Date:

April 2012

Related Keywords:

  • End Stage Renal Disease (ESRD)
  • Kidney Function
  • Genes
  • Association Analysis
  • Polymorphisms
  • Diabetes
  • Disease Susceptibility
  • Kidney Diseases
  • Kidney Failure, Chronic



National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland  20892